HEADER ISOMERASE 12-JAN-16 5HJ7 TITLE GLUTAMATE RACEMASE MYCOBACTERIUM TUBERCULOSIS (MURI) WITH BOUND D- TITLE 2 GLUTAMATE, 2.3 ANGSTROM RESOLUTION, X-RAY DIFFRACTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMATE RACEMASE; COMPND 3 CHAIN: A, B; COMPND 4 EC: 5.1.1.3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 STRAIN: ATCC 25618 / H37RV; SOURCE 6 GENE: MURI, RV1338, MTCY02B10.02, MTCY130.23; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET-28 KEYWDS GLUTAMATE RACEMASE TUBERCULOSIS DRUG DESIGN DIMER KINETICS, ISOMERASE EXPDTA X-RAY DIFFRACTION AUTHOR S.POEN,Y.NAKATANI,K.KRAUSE REVDAT 3 06-MAR-24 5HJ7 1 REMARK REVDAT 2 08-NOV-17 5HJ7 1 AUTHOR JRNL REMARK REVDAT 1 25-MAY-16 5HJ7 0 JRNL AUTH S.POEN,Y.NAKATANI,H.K.OPEL-READING,M.LASSE,R.C.DOBSON, JRNL AUTH 2 K.L.KRAUSE JRNL TITL EXPLORING THE STRUCTURE OF GLUTAMATE RACEMASE FROM JRNL TITL 2 MYCOBACTERIUM TUBERCULOSIS AS A TEMPLATE FOR JRNL TITL 3 ANTI-MYCOBACTERIAL DRUG DISCOVERY. JRNL REF BIOCHEM. J. V. 473 1267 2016 JRNL REFN ESSN 1470-8728 JRNL PMID 26964898 JRNL DOI 10.1042/BCJ20160186 REMARK 2 REMARK 2 RESOLUTION. 2.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (1.10.1_2155: ???) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.30 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.80 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.010 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 24014 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.157 REMARK 3 R VALUE (WORKING SET) : 0.154 REMARK 3 FREE R VALUE : 0.208 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1220 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.8487 - 4.7822 0.99 2699 137 0.1463 0.1766 REMARK 3 2 4.7822 - 3.7965 0.98 2598 148 0.1266 0.1562 REMARK 3 3 3.7965 - 3.3168 0.98 2590 149 0.1405 0.1878 REMARK 3 4 3.3168 - 3.0137 0.97 2539 142 0.1701 0.2486 REMARK 3 5 3.0137 - 2.7977 0.96 2517 145 0.1689 0.2071 REMARK 3 6 2.7977 - 2.6328 0.95 2509 125 0.1705 0.2815 REMARK 3 7 2.6328 - 2.5009 0.94 2465 131 0.1723 0.2453 REMARK 3 8 2.5009 - 2.3921 0.93 2443 114 0.1731 0.2436 REMARK 3 9 2.3921 - 2.3000 0.93 2434 129 0.1681 0.2338 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.220 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 19.640 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3906 REMARK 3 ANGLE : 0.867 5330 REMARK 3 CHIRALITY : 0.053 644 REMARK 3 PLANARITY : 0.006 706 REMARK 3 DIHEDRAL : 14.353 2360 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5HJ7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JAN-16. REMARK 100 THE DEPOSITION ID IS D_1000216598. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 16-JUN-13 REMARK 200 TEMPERATURE (KELVIN) : 93 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : AUSTRALIAN SYNCHROTRON REMARK 200 BEAMLINE : MX1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9537 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 210R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : NULL REMARK 200 DATA SCALING SOFTWARE : XDS, SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24018 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.300 REMARK 200 RESOLUTION RANGE LOW (A) : 42.800 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 5.000 REMARK 200 R MERGE (I) : 0.10300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 15.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.30 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.38 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.7 REMARK 200 DATA REDUNDANCY IN SHELL : 5.00 REMARK 200 R MERGE FOR SHELL (I) : 0.35400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 5.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NEEDLE SHAPE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.46 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG 10,000, 0.1 M HEPES, PH 7.5, REMARK 280 MICROBATCH, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+3/4 REMARK 290 4555 Y,-X,Z+1/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 30.86800 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.30200 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 15.43400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 3480 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19080 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -4.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MET A 1 REMARK 465 GLY A 256 REMARK 465 PRO A 257 REMARK 465 VAL A 258 REMARK 465 LEU A 259 REMARK 465 GLY A 260 REMARK 465 GLY A 261 REMARK 465 VAL A 262 REMARK 465 GLN A 263 REMARK 465 PRO A 264 REMARK 465 VAL A 265 REMARK 465 HIS A 266 REMARK 465 PRO A 267 REMARK 465 SER A 268 REMARK 465 ARG A 269 REMARK 465 ILE A 270 REMARK 465 HIS A 271 REMARK 465 LEU B 259 REMARK 465 GLY B 260 REMARK 465 GLY B 261 REMARK 465 VAL B 262 REMARK 465 GLN B 263 REMARK 465 PRO B 264 REMARK 465 VAL B 265 REMARK 465 HIS B 266 REMARK 465 PRO B 267 REMARK 465 SER B 268 REMARK 465 ARG B 269 REMARK 465 ILE B 270 REMARK 465 HIS B 271 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 529 O HOH B 408 2.06 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 82 11.89 -148.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DGL A 301 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue DGL B 301 DBREF 5HJ7 A 1 271 UNP P9WPW9 MURI_MYCTU 1 271 DBREF 5HJ7 B 1 271 UNP P9WPW9 MURI_MYCTU 1 271 SEQADV 5HJ7 SER A -1 UNP P9WPW9 EXPRESSION TAG SEQADV 5HJ7 HIS A 0 UNP P9WPW9 EXPRESSION TAG SEQADV 5HJ7 SER B -1 UNP P9WPW9 EXPRESSION TAG SEQADV 5HJ7 HIS B 0 UNP P9WPW9 EXPRESSION TAG SEQRES 1 A 273 SER HIS MET ASN SER PRO LEU ALA PRO VAL GLY VAL PHE SEQRES 2 A 273 ASP SER GLY VAL GLY GLY LEU THR VAL ALA ARG ALA ILE SEQRES 3 A 273 ILE ASP GLN LEU PRO ASP GLU ASP ILE VAL TYR VAL GLY SEQRES 4 A 273 ASP THR GLY ASN GLY PRO TYR GLY PRO LEU THR ILE PRO SEQRES 5 A 273 GLU ILE ARG ALA HIS ALA LEU ALA ILE GLY ASP ASP LEU SEQRES 6 A 273 VAL GLY ARG GLY VAL LYS ALA LEU VAL ILE ALA CYS ASN SEQRES 7 A 273 SER ALA SER SER ALA CYS LEU ARG ASP ALA ARG GLU ARG SEQRES 8 A 273 TYR GLN VAL PRO VAL VAL GLU VAL ILE LEU PRO ALA VAL SEQRES 9 A 273 ARG ARG ALA VAL ALA ALA THR ARG ASN GLY ARG ILE GLY SEQRES 10 A 273 VAL ILE GLY THR ARG ALA THR ILE THR SER HIS ALA TYR SEQRES 11 A 273 GLN ASP ALA PHE ALA ALA ALA ARG ASP THR GLU ILE THR SEQRES 12 A 273 ALA VAL ALA CYS PRO ARG PHE VAL ASP PHE VAL GLU ARG SEQRES 13 A 273 GLY VAL THR SER GLY ARG GLN VAL LEU GLY LEU ALA GLN SEQRES 14 A 273 GLY TYR LEU GLU PRO LEU GLN ARG ALA GLU VAL ASP THR SEQRES 15 A 273 LEU VAL LEU GLY CYS THR HIS TYR PRO LEU LEU SER GLY SEQRES 16 A 273 LEU ILE GLN LEU ALA MET GLY GLU ASN VAL THR LEU VAL SEQRES 17 A 273 SER SER ALA GLU GLU THR ALA LYS GLU VAL VAL ARG VAL SEQRES 18 A 273 LEU THR GLU ILE ASP LEU LEU ARG PRO HIS ASP ALA PRO SEQRES 19 A 273 PRO ALA THR ARG ILE PHE GLU ALA THR GLY ASP PRO GLU SEQRES 20 A 273 ALA PHE THR LYS LEU ALA ALA ARG PHE LEU GLY PRO VAL SEQRES 21 A 273 LEU GLY GLY VAL GLN PRO VAL HIS PRO SER ARG ILE HIS SEQRES 1 B 273 SER HIS MET ASN SER PRO LEU ALA PRO VAL GLY VAL PHE SEQRES 2 B 273 ASP SER GLY VAL GLY GLY LEU THR VAL ALA ARG ALA ILE SEQRES 3 B 273 ILE ASP GLN LEU PRO ASP GLU ASP ILE VAL TYR VAL GLY SEQRES 4 B 273 ASP THR GLY ASN GLY PRO TYR GLY PRO LEU THR ILE PRO SEQRES 5 B 273 GLU ILE ARG ALA HIS ALA LEU ALA ILE GLY ASP ASP LEU SEQRES 6 B 273 VAL GLY ARG GLY VAL LYS ALA LEU VAL ILE ALA CYS ASN SEQRES 7 B 273 SER ALA SER SER ALA CYS LEU ARG ASP ALA ARG GLU ARG SEQRES 8 B 273 TYR GLN VAL PRO VAL VAL GLU VAL ILE LEU PRO ALA VAL SEQRES 9 B 273 ARG ARG ALA VAL ALA ALA THR ARG ASN GLY ARG ILE GLY SEQRES 10 B 273 VAL ILE GLY THR ARG ALA THR ILE THR SER HIS ALA TYR SEQRES 11 B 273 GLN ASP ALA PHE ALA ALA ALA ARG ASP THR GLU ILE THR SEQRES 12 B 273 ALA VAL ALA CYS PRO ARG PHE VAL ASP PHE VAL GLU ARG SEQRES 13 B 273 GLY VAL THR SER GLY ARG GLN VAL LEU GLY LEU ALA GLN SEQRES 14 B 273 GLY TYR LEU GLU PRO LEU GLN ARG ALA GLU VAL ASP THR SEQRES 15 B 273 LEU VAL LEU GLY CYS THR HIS TYR PRO LEU LEU SER GLY SEQRES 16 B 273 LEU ILE GLN LEU ALA MET GLY GLU ASN VAL THR LEU VAL SEQRES 17 B 273 SER SER ALA GLU GLU THR ALA LYS GLU VAL VAL ARG VAL SEQRES 18 B 273 LEU THR GLU ILE ASP LEU LEU ARG PRO HIS ASP ALA PRO SEQRES 19 B 273 PRO ALA THR ARG ILE PHE GLU ALA THR GLY ASP PRO GLU SEQRES 20 B 273 ALA PHE THR LYS LEU ALA ALA ARG PHE LEU GLY PRO VAL SEQRES 21 B 273 LEU GLY GLY VAL GLN PRO VAL HIS PRO SER ARG ILE HIS HET DGL A 301 10 HET DGL B 301 10 HETNAM DGL D-GLUTAMIC ACID FORMUL 3 DGL 2(C5 H9 N O4) FORMUL 5 HOH *310(H2 O) HELIX 1 AA1 GLY A 17 LEU A 28 1 12 HELIX 2 AA2 THR A 48 ARG A 66 1 19 HELIX 3 AA3 CYS A 75 TYR A 90 1 16 HELIX 4 AA4 ILE A 98 THR A 109 1 12 HELIX 5 AA5 THR A 119 SER A 125 1 7 HELIX 6 AA6 HIS A 126 PHE A 132 1 7 HELIX 7 AA7 ALA A 133 ALA A 135 5 3 HELIX 8 AA8 ARG A 147 ARG A 154 1 8 HELIX 9 AA9 GLY A 159 ALA A 176 1 18 HELIX 10 AB1 HIS A 187 LEU A 190 5 4 HELIX 11 AB2 LEU A 191 GLY A 200 1 10 HELIX 12 AB3 SER A 208 ILE A 223 1 16 HELIX 13 AB4 ASP A 243 LEU A 255 1 13 HELIX 14 AB5 GLY B 17 LEU B 28 1 12 HELIX 15 AB6 THR B 48 ARG B 66 1 19 HELIX 16 AB7 CYS B 75 TYR B 90 1 16 HELIX 17 AB8 ILE B 98 THR B 109 1 12 HELIX 18 AB9 THR B 119 SER B 125 1 7 HELIX 19 AC1 HIS B 126 PHE B 132 1 7 HELIX 20 AC2 ALA B 133 ALA B 135 5 3 HELIX 21 AC3 ARG B 147 ARG B 154 1 8 HELIX 22 AC4 GLY B 159 ALA B 176 1 18 HELIX 23 AC5 HIS B 187 LEU B 190 5 4 HELIX 24 AC6 LEU B 191 GLY B 200 1 10 HELIX 25 AC7 SER B 208 ILE B 223 1 16 HELIX 26 AC8 ASP B 243 GLY B 256 1 14 SHEET 1 AA1 5 VAL A 94 GLU A 96 0 SHEET 2 AA1 5 ALA A 70 ILE A 73 1 N ILE A 73 O VAL A 95 SHEET 3 AA1 5 VAL A 8 ASP A 12 1 N GLY A 9 O VAL A 72 SHEET 4 AA1 5 ILE A 33 GLY A 37 1 O VAL A 34 N VAL A 10 SHEET 5 AA1 5 ARG A 236 ALA A 240 1 O ILE A 237 N TYR A 35 SHEET 1 AA2 4 GLU A 139 ALA A 144 0 SHEET 2 AA2 4 ARG A 113 GLY A 118 1 N ILE A 114 O GLU A 139 SHEET 3 AA2 4 THR A 180 LEU A 183 1 O THR A 180 N GLY A 115 SHEET 4 AA2 4 THR A 204 SER A 207 1 O VAL A 206 N LEU A 183 SHEET 1 AA3 5 VAL B 94 GLU B 96 0 SHEET 2 AA3 5 ALA B 70 ILE B 73 1 N LEU B 71 O VAL B 95 SHEET 3 AA3 5 VAL B 8 ASP B 12 1 N GLY B 9 O ALA B 70 SHEET 4 AA3 5 ILE B 33 GLY B 37 1 O VAL B 34 N VAL B 10 SHEET 5 AA3 5 ARG B 236 ALA B 240 1 O ILE B 237 N TYR B 35 SHEET 1 AA4 4 GLU B 139 ALA B 144 0 SHEET 2 AA4 4 ARG B 113 GLY B 118 1 N ILE B 114 O GLU B 139 SHEET 3 AA4 4 THR B 180 LEU B 183 1 O THR B 180 N GLY B 115 SHEET 4 AA4 4 THR B 204 SER B 207 1 O VAL B 206 N LEU B 183 CISPEP 1 GLY A 42 PRO A 43 0 0.10 CISPEP 2 GLY B 42 PRO B 43 0 -0.45 SITE 1 AC1 13 ASP A 12 SER A 13 PRO A 43 TYR A 44 SITE 2 AC1 13 GLY A 45 CYS A 75 ASN A 76 SER A 77 SITE 3 AC1 13 THR A 119 CYS A 185 THR A 186 HOH A 439 SITE 4 AC1 13 HOH A 450 SITE 1 AC2 14 ASP B 12 SER B 13 PRO B 43 TYR B 44 SITE 2 AC2 14 GLY B 45 CYS B 75 ASN B 76 SER B 77 SITE 3 AC2 14 THR B 119 CYS B 185 THR B 186 HIS B 187 SITE 4 AC2 14 HOH B 442 HOH B 448 CRYST1 95.796 95.796 61.736 90.00 90.00 90.00 P 43 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010439 0.000000 0.000000 0.00000 SCALE2 0.000000 0.010439 0.000000 0.00000 SCALE3 0.000000 0.000000 0.016198 0.00000